Skip Navigation

European Heart Journal 1991 12(5):583-589;
Copyright © 1991 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by CHAKRABARTY, S.
Right arrow Articles by SHERIDAN, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHAKRABARTY, S.
Right arrow Articles by SHERIDAN, D. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 The European Society of Cardiology

Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia

S. CHAKRABARTY, P. THOMAS and D. J. SHERIDAN

Academic Cardiology Unit, St Mary's Hospital Medical School London W2

Received 26 June 1990; revised 7 September 1990; .

Correspondence: Professor D. J. Sheridan, Academic Cardiology Unit, St Mary's Hospital Medical School, 10th Floor Q.E.Q.M. Wing, South Wharf Road, London W2 1NY, U.K.

Abstract

The effects of alterations in platelet activity on arrhythmias, haemodynamics and extent of necrosis during coronary ligation for 30 min were assessed in rabbits. Reductions of platelet counts to less than 1% of control by intravenous injection of platelet antiserum (1 ml kg–1 i.v.) reduced the volume of necrosed tissue from 23±2% to 15±1%, P <0·01 (expressed as % of total LV) and attenuated the hypotensive effect of ischaemia. Pretreatment with the platelet activating factor (PAF) antagonist BN 52021 also attenuated the hypotension and necrosis caused by coronary ligation 23±2% vs 14±1%, P<0·01. Pretreatment with the thromboxane antagonist CGS 13080 attenuated the hypotensive response to ischaemia but had only a very small effect on the area of necrosis. Administration of PAF at 10 min following coronary ligation markedly increased the volume of necrosed tissue 36±2%, P <0·01 and caused VF and haemodynamic collapse in 10 out of 12 animals. Pretreatment with platelet antiserum or the PAF antagonist BN 52021 reversed this effect of PAF. Pretreatment with CGS 13080 attenuated the marked hypotensive effect of PAF but failed to reverse its necrotic or arrhythmogenic effects.

These findings indicate that platelet activation contributes to the necrosis and hypotension following coronary ligation and that platelet-activating factor may contribute to this. The ameliorating effects of platelet antiserum or BN 52021 support the concept that inhibition of platelet activity may have a useful role in the treatment of acute myocardial infarction.

Key Words: Myocardial ischaemia • platelets • platelet activating factor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. J. Leary, S. Rajasekaran, R. R. Morrison, E. I. Tuomanen, T. K. Chin, and P. A. Hofmann
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2775 - H2784.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. Montrucchio, G. Alloatti, and G. Camussi
Role of Platelet-Activating Factor in Cardiovascular Pathophysiology
Physiol Rev, October 1, 2000; 80(4): 1669 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. K. Qayumi, J. C. English, D. V. Godin, D. M. Ansley, E. B. Loucks, J. U. Lee, and C.-W. Kim
The Role of Platelet-Activating Factor in Regional Myocardial Ischemia-Reperfusion Injury
Ann. Thorac. Surg., June 1, 1998; 65(6): 1690 - 1697.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.